Colorectal Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colorectal Cancer, including details on symptoms, genetics, screening, treatment, information.

Volume 4 (2007), Issue 11 (November)

1. K-ras mutations and mucin profile in preneoplastic lesions and colon tumors induced in rats by 1,2-dimethylhydrazine.
   Int J Cancer, 122(1): 117-23. [Abstract] [Full-text]
2. S-adenosyl L-methionine inhibits azoxymethane-induced colonic aberrant crypt foci in F344 rats and suppresses human colon cancer Caco-2 cell growth in 3D culture.
   Int J Cancer, 122(1): 25-30. [Abstract] [Full-text]
3. Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells.
   J Biol Chem, 282(45): 32582-90. [Abstract] [Full-text]
4. Pyogenic liver abscess presenting after malignant polypectomy.
   Dig Dis Sci, 52(12): 3524-5. [Abstract] [Full-text]
5. Genotyping of CYP3A5 polymorphisms among Bulgarian patients with sporadic colorectal cancer and controls.
   Onkologie, 30(11): 559-63. [Abstract] [Full-text]
6. Cancer mucosa antigens as a novel immunotherapeutic class of tumor-associated antigen.
   Clin Pharmacol Ther, 82(6): 734-9. [Abstract] [Full-text]
7. Nitric oxide-donating aspirin derivatives suppress microsatellite instability in mismatch repair-deficient and hereditary nonpolyposis colorectal cancer cells.
   Cancer Res, 67(22): 10966-75. [Abstract] [Full-text]
8. Prolonged chronic inflammation progresses to dysplasia in a novel rat model of colitis-associated colon cancer.
   Cancer Res, 67(22): 10766-73. [Abstract] [Full-text]
9. Common and distinct genomic events in sporadic colorectal cancer and diverse cancer types.
   Cancer Res, 67(22): 10736-43. [Abstract] [Full-text]
10. The metastatic lymph node ratio predicts survival in colon cancer.
    Am J Surg, 194(6): 827-31; discussion 831-2. [Abstract] [Full-text]
11. Incidence of fertility counseling of women of child-bearing age before treatment for colorectal cancer.
    Am J Surg, 194(6): 765-7; discussion 767-8. [Abstract] [Full-text]
12. Cetuximab for the treatment of colorectal cancer.
    N Engl J Med, 357(20): 2040-8. [Abstract] [Full-text]
13. Hospital lymph node examination rates and survival after resection for colon cancer.
    JAMA, 298(18): 2149-54. [Abstract] [Full-text]
14. The genomic landscapes of human breast and colorectal cancers.
    Science, 318(5853): 1108-13. [Abstract] [Full-text]
15. Laparoscopic total proctocolectomy with ileal pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis: initial experience in Mexico.
    Surg Endosc, 21(12): 2304-7. [Abstract] [Full-text]
16. Comparison of conventional laparoscopic and hand-assisted oncologic segmental colonic resection.
    Surg Endosc, 21(12): 2137-41. [Abstract] [Full-text]
17. Factors affecting the number of lymph nodes retrieved in colorectal cancer specimens.
    Surg Endosc, 21(12): 2142-6. [Abstract] [Full-text]
18. Wound infection after elective laparoscopic surgery for colorectal carcinoma.
    Surg Endosc, 21(12): 2248-52. [Abstract] [Full-text]
19. Costs and cost-effectiveness of a low-intensity patient-directed intervention to promote colorectal cancer screening.
    J Clin Oncol, 25(33): 5248-53. [Abstract] [Full-text]
20. Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer.
    J Clin Oncol, 25(33): 5225-32. [Abstract] [Full-text]
21. Progression-free survival is a surrogate for survival in advanced colorectal cancer.
    J Clin Oncol, 25(33): 5218-24. [Abstract] [Full-text]
22. Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer.
    J Clin Oncol, 25(33): 5158-64. [Abstract] [Full-text]
23. Perioperative sargramostim (recombinant human GM-CSF) induces an increase in the level of soluble VEGFR1 in colon cancer patients undergoing minimally invasive surgery.
    Eur J Surg Oncol, 33(10): 1169-76. [Abstract] [Full-text]
24. Detection of metastatic disease with sentinel lymph node dissection in colorectal carcinoma patients.
    Eur J Surg Oncol, 33(10): 1183-90. [Abstract] [Full-text]
25. Ex vivo sentinel lymph node "mapping" in colorectal cancer.
    Eur J Surg Oncol, 33(10): 1177-82. [Abstract] [Full-text]
26. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience.
    Eur J Surg Oncol, 33(10): 1199-206. [Abstract] [Full-text]
27. A study of dendritic and endothelial cell interactions in colon cancer in a cell line and small mammal model.
    Eur J Surg Oncol, 33(10): 1191-8. [Abstract] [Full-text]
28. Thymosin beta 4 expression and nuclear transport are regulated by hMLH1.
    Biochem Biophys Res Commun, 364(4): 731-6. [Abstract] [Full-text]
29. CYP27A1 and CYP24 expression as a function of malignant transformation in the colon.
    J Histochem Cytochem, 55(12): 1257-64. [Abstract] [Full-text]
30. Inhibitory effect of phytoglycoprotein on tumor necrosis factor-alpha and interleukin-6 at initiation stage of colon cancer in 1,2-dimethylhydrazine-treated ICR mice.
    Toxicol Appl Pharmacol, 225(2): 198-205. [Abstract] [Full-text]
31. Intrinsic resistance to apoptosis of colon epithelial cells is a potential determining factor in the susceptibility of the A/J mouse strain to dimethylhydrazine-induced colon tumorigenesis.
    Mol Carcinog, 46(12): 993-1002. [Abstract] [Full-text]
32. A phase II study of irinotecan in combination with doxifluridine, an intermediate form of capecitabine, in patients with metastatic colorectal cancer.
    Cancer Chemother Pharmacol, 61(2): 275-81. [Abstract] [Full-text]
33. Phase-II study of dose attenuated schedule of irinotecan, capecitabine, and celecoxib in advanced colorectal cancer.
    Cancer Chemother Pharmacol, 61(2): 283-9. [Abstract] [Full-text]
34. Quality assessment for CT colonography: validation of automated measurement of colonic distention and residual fluid.
    AJR Am J Roentgenol, 189(6): 1457-63. [Abstract] [Full-text]
35. Association between cigarette smoking and colorectal cancer in the Women's Health Initiative.
    J Natl Cancer Inst, 99(22): 1729-35. [Abstract] [Full-text]
36. Systematic evaluation of surgical strategies for acute malignant left-sided colonic obstruction.
    Br J Surg, 94(12): 1451-60. [Abstract] [Full-text]
37. Achieving R0 resection in the colorectum using endoscopic submucosal dissection.
    Br J Surg, 94(12): 1536-42. [Abstract] [Full-text]
38. Clinicopathological significance of fibrous tissue around fixed recurrent rectal cancer in the pelvis.
    Br J Surg, 94(12): 1530-5. [Abstract] [Full-text]
39. Laparoscopic approach in surgical treatment of rectal cancer.
    Br J Surg, 94(12): 1555-61. [Abstract] [Full-text]
40. Impact of anastomotic leakage on oncological outcome after rectal cancer resection.
    Br J Surg, 94(12): 1548-54. [Abstract] [Full-text]
41. Selecting patients with young-onset colorectal cancer for mismatch repair gene analysis.
    Br J Surg, 94(12): 1567-71. [Abstract] [Full-text]
42. Urodynamic outcome of waterjet-assisted total mesorectal excision.
    Br J Surg, 94(12): 1543-7. [Abstract] [Full-text]
43. Anastomotic leakage after elective right versus left colectomy for cancer: prevalence and independent risk factors.
    J Am Coll Surg, 205(6): 785-93. [Abstract] [Full-text]
44. Clinical relevance of the expression of mRNA of MMP-7, MMP-9, TIMP-1, TIMP-2 and CEA tissue samples from colorectal liver metastases.
    Tumour Biol, 28(5): 247-52. [Abstract] [Full-text]
45. Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer.
    Proc Natl Acad Sci U S A, 104(47): 18654-9. [Abstract] [Full-text]
46. Colon carcinogenesis in liver-specific IGF-I-deficient (LID) mice.
    Int J Cancer, 122(2): 472-6. [Abstract] [Full-text]
47. Misclassification of colorectal cancer stage and area variation in survival.
    Int J Cancer, 122(2): 398-402. [Abstract] [Full-text]
48. Spindle proteins Aurora A and BUB1B, but not Mad2, are aberrantly expressed in dysplastic mucosa of patients with longstanding ulcerative colitis.
    J Clin Pathol, 60(12): 1403-8. [Abstract] [Full-text]
49. Continuous oral capecitabine at fixed dose in patients older than 75 years with metastatic colorectal and gastric cancer: a study of the Multidisciplinary Oncology Group on Gastrointestinal Tumors.
    Anticancer Drugs, 19(1): 91-6. [Abstract] [Full-text]
50. Norcantharidin induces anoikis through Jun-N-terminal kinase activation in CT26 colorectal cancer cells.
    Anticancer Drugs, 19(1): 55-64. [Abstract] [Full-text]
51. Exposure-response relationships for oxaliplatin-treated colon cancer cells.
    Anticancer Drugs, 19(1): 37-44. [Abstract] [Full-text]
52. Phase II study of uracil-tegafur with leucovorin in elderly (> or = 75 years old) patients with colorectal cancer: ECOG 1299.
    J Clin Oncol, 25(34): 5397-402. [Abstract] [Full-text]
53. Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption.
    J Clin Oncol, 25(34): 5390-6. [Abstract] [Full-text]

© 2004-2008 Colorectal Cancer Research Today. All Rights Reserved.